What is the appropriate workup for a patient with an absolute lymphocyte count of 748 cells per microliter?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Workup for Absolute Lymphocyte Count of 748 cells/μL

An absolute lymphocyte count of 748 cells/μL represents lymphopenia and requires a focused workup to exclude chronic lymphocytic leukemia (CLL), HIV infection, and other causes of immunosuppression before determining if observation alone is appropriate.

Initial Diagnostic Steps

1. Flow Cytometry Immunophenotyping

The first critical test is flow cytometry of peripheral blood to evaluate for CLL or other lymphoproliferative disorders 1, 2. This is essential because:

  • CLL requires ≥5,000 B lymphocytes/μL for diagnosis, but your patient's count is below this threshold
  • However, monoclonal B-lymphocytosis (MBL) can exist with counts <5,000/μL and progresses to CLL at 1-2% per year 2
  • Flow cytometry will identify if clonal B cells are present expressing CD5, CD19, CD20, CD23 with low surface immunoglobulin (the CLL phenotype) 2

2. HIV Testing

HIV serology is mandatory given the lymphocyte count of 748 cells/μL 3, 4, 5. The evidence shows:

  • An ALC <1,000 cells/μL predicts CD4 count <200 cells/μL with 91% positive predictive value 3
  • An ALC <950 cells/μL has a positive likelihood ratio of 10.1 for CD4 <200 cells/μL in HIV+ patients 4
  • If HIV-positive, proceed with CD4 count measurement to determine need for antiretroviral therapy and opportunistic infection prophylaxis

3. Complete Blood Count with Differential

Review the full CBC parameters to assess:

  • Presence of anemia (Hb <10 g/dL) or thrombocytopenia (platelets <100,000/μL), which would suggest marrow failure 1, 2
  • Neutrophil count and neutrophil-to-lymphocyte ratio
  • Presence of atypical lymphocytes or smudge cells on peripheral smear 2

4. Physical Examination Findings

Document specific findings that indicate active disease requiring treatment 1, 2:

  • Lymphadenopathy: Measure if nodes are ≥10 cm in longest diameter or progressive
  • Splenomegaly: Assess if spleen extends ≥6 cm below left costal margin
  • Constitutional symptoms: Unintentional weight loss ≥10% in 6 months, significant fatigue (ECOG PS ≥2), fevers >38°C for ≥2 weeks, or night sweats >1 month

Additional Workup Based on Initial Results

If Flow Cytometry Shows Clonal B Cells:

  • FISH panel for del(17p), del(11q), trisomy 12, del(13q) 1
  • IGHV mutational status 1
  • TP53 mutation analysis 1
  • CT scans only if lymphadenopathy or organomegaly detected on exam 2

If HIV-Positive:

  • CD4 count and viral load
  • Initiate appropriate prophylaxis if CD4 <200 cells/μL

If Both Negative:

Evaluate for secondary causes of lymphopenia:

  • Autoimmune disorders (ANA, rheumatoid factor)
  • Medications causing bone marrow suppression
  • Nutritional deficiencies (vitamin B12, folate)
  • Recent viral infections
  • Chronic kidney or liver disease

Key Clinical Pitfall

Do not assume lymphopenia alone requires treatment. Even if CLL/MBL is identified, the absolute lymphocyte count itself is NOT an indication for therapy 2. The guidelines explicitly state that "the absolute lymphocyte count should not be used as the sole indicator for treatment" 2. Treatment is only indicated when criteria for "active disease" are met (progressive marrow failure, massive/progressive organomegaly, constitutional symptoms, or lymphocyte doubling time <6 months with initial count >30,000/μL) 1, 2.

Observation Strategy if No Active Disease Found

If workup reveals no malignancy, HIV, or treatable cause:

  • Repeat CBC with differential every 3-6 months
  • Monitor for development of infections or autoimmune complications
  • Re-evaluate if ALC continues to decline or symptoms develop

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.